{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T16:27:50Z","timestamp":1763224070116},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9,10]]},"DOI":"10.1097\/qad.0b013e328362fe42","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T12:44:18Z","timestamp":1368276258000},"page":"2219-2224","source":"Crossref","is-referenced-by-count":15,"title":["Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B"],"prefix":"10.1097","volume":"27","author":[{"given":"Zulema","family":"Plaza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Mena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Vispo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Sierra-Enguita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Pedreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Barreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"del Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Poveda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B.","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"R2-8-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2009.11.009","article-title":"Epidemiology of hepatitis B and C viruses: a global overview.","volume":"14","author":"Te","year":"2010","journal-title":"Clin Liver Dis"},{"key":"R3-8-20210130","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data.","volume":"58","author":"Blachier","year":"2013","journal-title":"J Hepatol"},{"key":"R4-8-20210130","first-page":"27","article-title":"Hepatitis B virus co-infection in HIV-infected subjects.","volume":"4","author":"Puoti","year":"2002","journal-title":"AIDS Rev"},{"key":"R5-8-20210130","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/377135","article-title":"Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in HIV-infected subjects.","volume":"188","author":"Kellerman","year":"2003","journal-title":"J Infect Dis"},{"key":"R6-8-20210130","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.aids.0000163936.99401.fe","article-title":"Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.","volume":"19","author":"Konopnicki","year":"2005","journal-title":"AIDS"},{"key":"R7-8-20210130","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter AIDS Cohort study (MACS).","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"key":"R8-8-20210130","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/01.aids.0000163948.62176.e7","article-title":"Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.","volume":"19","author":"Soriano","year":"2005","journal-title":"AIDS"},{"key":"R9-8-20210130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-0032-1316466","article-title":"Hepatitis B virus and HIV infection.","volume":"32","author":"Martin-Carbonero","year":"2012","journal-title":"Semin Liver Dis"},{"key":"R10-8-20210130","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/520752","article-title":"Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.","volume":"45","author":"Miailhes","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R11-8-20210130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/QAD.0b013e328334bddb","article-title":"Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption.","volume":"24","author":"Dore","year":"2010","journal-title":"AIDS"},{"key":"R12-8-20210130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1310\/hct0705-246","article-title":"Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity.","volume":"7","author":"Maida","year":"2006","journal-title":"HIV Clin Trials"},{"key":"R13-8-20210130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1310\/hct1003-153","article-title":"Longer duration of HBV-active antiretroviral therapy is linked to favorable virological outcome in HIV-HBV co-infected patients.","volume":"10","author":"Lee","year":"2009","journal-title":"HIV Clin Trials"},{"key":"R14-8-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/QAD.0b013e328340fde2","article-title":"Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues.","volume":"25","author":"Martin-Carbonero","year":"2011","journal-title":"AIDS"},{"key":"R16-8-20210130","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1097\/00002030-200211220-00023","article-title":"Activity of tenofovir on hepatitis B virus replication in HIV-coinfected patients failing or partially responding to lamivudine.","volume":"16","author":"Nunez","year":"2002","journal-title":"AIDS"},{"key":"R17-8-20210130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/gut.2010.223206","article-title":"Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B.","volume":"60","author":"Patterson","year":"2011","journal-title":"Gut"},{"key":"R18-8-20210130","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0140-6736(03)15108-2","article-title":"Viral hepatitis B.","volume":"362","author":"Lai","year":"2003","journal-title":"Lancet"},{"key":"R19-8-20210130","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2006.01.001","article-title":"HBV drug resistance: mechanisms, detection and interpretation.","volume":"44","author":"Shaw","year":"2006","journal-title":"J Hepatol"},{"key":"R20-8-20210130","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/hep.510300525","article-title":"Long-term incidence of hepatitis B virus resistance to lamivudine in HIV-infected patients.","volume":"30","author":"Benhamou","year":"1999","journal-title":"Hepatology"},{"key":"R21-8-20210130","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1086\/593105","article-title":"Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions.","volume":"47","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R22-8-20210130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jama.2012.7961","article-title":"Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.","volume":"308","author":"Thompson","year":"2012","journal-title":"JAMA"},{"key":"R26-8-20210130","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1086\/656624","article-title":"Review of hepatitis B therapeutics.","volume":"51","author":"Bhattacharya","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R27-8-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.23246","article-title":"Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleosidenucleotide analogues.","volume":"51","author":"Van Bommel","year":"2010","journal-title":"Hepatology"},{"key":"R28-8-20210130","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1128\/AAC.02600-12","article-title":"Efficacy of tenofovir in patients with lamivudine failure is not different from that in nucleosidenucleotide analogue-naive patient with chronic hepatitis B.","volume":"57","author":"Baran","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-8-20210130","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1097\/01.aids.0000247116.89455.5d","article-title":"Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV coinfection.","volume":"20","author":"Schmutz","year":"2006","journal-title":"AIDS"},{"key":"R30-8-20210130","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s10620-012-2402-2","article-title":"Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for entecavir partial responders.","volume":"57","author":"Yip","year":"2012","journal-title":"Dig Dis Sci"},{"key":"R31-8-20210130","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/jac\/dkp479","article-title":"Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe.","volume":"65","author":"Soriano","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R32-8-20210130","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1097\/QAD.0b013e32834babb3","article-title":"Hepatitis delta in HIV-infected individuals in Europe.","volume":"25","author":"Soriano","year":"2011","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e328362fe42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:36:02Z","timestamp":1620970562000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201309100-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,10]]},"references-count":28,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328362fe42","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,10]]}}}